News Daily News FDA Issues Early Alert About Risks of Peripheral Atherectomy Device L.A. McKeown February 07, 2025
News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Conference News VIVA 2024 It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now? L.A. McKeown November 14, 2024
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024
Presentation TCT 2024 TCT 500: Long-term Outcomes and Predictor of Target Lesion Revascularization the Patients After Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis Presenter: Ikuta Akihiro October 29, 2024
Presentation TCT 2024 TCT 498: Predictors of Larger Final Lumen Expansion After Treatment of In-Stent Restenosis With Fibrotic Neointimal Hyperplasia Presenter: Takehiko Kido October 29, 2024
Presentation TCT 2024 TCT 499: Predictors of Good Final Lumen Expansion After Treatment of Severe In-Stent Restenosis Neoatherosclerosis as Evaluated by Intravascular Ultrasound Presenter: Takehiko Kido October 29, 2024
Presentation TCT 2024 TCT 501: Paclitaxel-Coated Balloon vs. Uncoated Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Presenter: Dealla Samadi October 29, 2024
Presentation TCT 2024 TCT 1103: Simple Solution for Stent Restenosis Due to Non-Expandable Calcified Lesions: A Clinical Case Presenter: QUAN NGUYEN MANH October 29, 2024
Presentation TCT 2024 TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model Presenter: Seok Oh October 29, 2024
Presentation TCT 2024 TCT 495: The Impact of Cutting Balloon Pre-Dilation on the Outcomes of Paclitaxel Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis Presenter: Yuanji Ma October 29, 2024
Presentation TCT 2024 TCT 496: Long-term Clinical Outcomes of Drug-Coated Balloons for the Treatment of In-Stent Chronic Total Occlusions Presenter: Jiasheng Yin October 29, 2024
Presentation TCT 2024 TCT 494: Between a Stent and a Hard Place: Insights Into Percutaneous Coronary Interventions and In-Stent Restenosis in Cancer Patients Presenter: Teodora Donisan October 29, 2024
Presentation TCT 2024 TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials Presenter: Michael Sabina October 29, 2024
Presentation TCT 2024 TCT 497: Sex-Specific Clinical Outcomes After Treatment of In-Stent Restenosis With the AGENT Paclitaxel-Coated Balloon: A Subgroup Analysis of the AGENT IDE Randomized Trial Presenter: Jennifer Tremmel October 29, 2024
Presentation TCT 2024 TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis Presenter: Leonardo Sinnott Silva October 29, 2024
Presentation TCT 2024 TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents? Presenter: Han Chen October 29, 2024
Presentation TCT 2024 TCT 315: Acute and Long-Term Safety and Efficacy of IVUS-Guided Drug Coated Balloon Treatment for Carotid In-Stent Restenosis Presenter: Piero Montorsi October 29, 2024